Suppr超能文献

对肿瘤相关碳酸酐酶IX和XII具有强效和选择性抑制作用的咔嗒尾香豆素。

Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.

作者信息

Nocentini Alessio, Carta Fabrizio, Ceruso Mariangela, Bartolucci Gianluca, Supuran Claudiu T

机构信息

Università degli Studi di Firenze, Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche, Polo Scientifico, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.

Università degli Studi di Firenze, Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche, Polo Scientifico, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy; Università degli Studi di Firenze, Dipartimento di Chimica, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy.

出版信息

Bioorg Med Chem. 2015 Nov 1;23(21):6955-66. doi: 10.1016/j.bmc.2015.09.041. Epub 2015 Sep 28.

Abstract

Coumarins behave as inhibitors of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) with a mechanism of inhibition distinct from other classes of inhibitors. A series of 7-substituted coumarins incorporating aryl-triazole moieties were prepared by click chemistry procedures starting from 7-hydroxycoumarin or 4-methyl-7-aminocoumarin. The panel of new compounds was assayed for the inhibition of the cytosolic, widespread human (h) isoforms hCA I and II, and the transmembrane, tumor-associated ones hCA IX and XII. Most of the coumarins were weak inhibitors or did not inhibit significantly hCA I and II, but showed low nanomolar inhibitory action against the transmembrane isoforms (K(I) of 14.3-34.4 nM against hCA IX and of 4.7-37.8 nM against hCA XII). Since many hypoxic tumors overexpress hCA IX/XII, and as these targets were recently validated for obtaining antitumor/antimetastatic agents, with one inhibitor in Phase I clinical trials, the present findings constitute an interesting extension to the knowledge of non-sulfonamide, selective inhibitors of CA isoforms involved in serious pathologies.

摘要

香豆素类化合物作为金属酶碳酸酐酶(CA,EC 4.2.1.1)的抑制剂,其抑制机制与其他类型的抑制剂不同。以7-羟基香豆素或4-甲基-7-氨基香豆素为起始原料,通过点击化学方法制备了一系列含有芳基三唑部分的7-取代香豆素。对这一系列新化合物进行了检测,以评估它们对胞质中广泛存在的人(h)同工型hCA I和II,以及跨膜的、与肿瘤相关的同工型hCA IX和XII的抑制作用。大多数香豆素是弱抑制剂,或对hCA I和II没有显著抑制作用,但对跨膜同工型显示出低纳摩尔级的抑制作用(对hCA IX的K(I)为14.3 - 34.4 nM,对hCA XII的K(I)为4.7 - 37.8 nM)。由于许多缺氧肿瘤过度表达hCA IX/XII,并且由于这些靶点最近已被确认为可用于获得抗肿瘤/抗转移药物,其中一种抑制剂已进入I期临床试验,因此本研究结果是对参与严重疾病的CA同工型非磺酰胺类选择性抑制剂知识的有趣扩展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验